10:47 AM EST - Psyence Group Inc. : Through its wholly-owned subsidiary Psyence Therapeutics Corp., the company announced it has entered into a Research Collaboration Agreement with MycoMeditations Inc., a leading psilocybin retreat provider to conduct an observational study of the efficacy of naturally derived psilocybin. The Psyence Group is a leading platform in naturally derived psychedelic therapy and the development and commercialization of related technologies and products. MycoMeditations is the leading global provider of psilocybin-assisted therapeutic retreat experiences in Jamaica, with a record of more than 750 guests successfully completing psilocybin-assisted retreats. Psyence Group Inc.
shares C.PSYG are trading off 1.06 percent at $0.47.
